Tyra Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $496 | $0 |
Gross Profit | -140 | -143 | 248 | -127 |
EBITDA | -31,312 | -31,707 | -29,600 | -28,477 |
EBIT | -31,452 | -31,850 | -29,744 | -28,604 |
Net Income | -28,098 | -28,147 | -25,571 | -24,016 |
Net Change In Cash | 0 | 0 | 496 | 0 |
Free Cash Flow | -23,711 | -25,472 | -19,596 | -17,950 |
Cash | 98,490 | 100,721 | 91,966 | 103,892 |
Basic Shares | 59,550 | 59,336 | 58,874 | 58,874 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -519 | -353 | -296 | -140 |
EBITDA | -85,962 | -79,592 | -58,631 | -26,148 |
EBIT | -86,481 | -79,945 | -58,927 | -26,288 |
Net Income | -86,481 | -69,134 | -51,723 | -26,141 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -50,212 | 286,958 | ||
Free Cash Flow | -70,438 | -50,909 | -50,844 | -24,406 |
Cash | 91,966 | 58,006 | 251,213 | 302,182 |
Basic Shares | 57,217 | 42,704 | 41,883 | 41,441 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.47 |
2025-03-31 | -$0.47 |
2024-12-31 | -$0.43 |
